Navigation Links
Zimmer Holdings, Inc. Reports First Quarter Financial Results
Date:4/24/2008

Basic $1.03 $0.99 4

Diluted $1.02 $0.98 4

Weighted Average Common Shares

Outstanding

Basic 232.5 236.9

Diluted 233.9 239.2

ZIMMER HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions)

March 31, December 31,

2008 2007

(unaudited)

Assets

Current Assets:

Cash and equivalents $476.0 $463.9

Restricted cash 2.8 2.5

Receivables, net 759.3 674.3

Inventories, net 756.6 727.8

Other current assets 227.9 214.2

Total current assets 2,222.6 2,082.7

Property, plant and equipment, net 1,039.0 971.9

Goodwill 2,712.7 2,621.4

Intangible assets, net 734.8 743.8

Other assets 210.1 213.9

Total Assets $6,919.2 $6,633.7

Liabilities and Shareholders' Equity

Current liabilities $789.2 $748.6

Other long-term liabilities 303.6 328.4

Long-term debt 116.9 104.3

Minority interest 3.0 2.8

Sh
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
3. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
4. Zimmer Holdings to Present at Upcoming Investor Conferences
5. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
6. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
7. Zimmer Holdings to Present at JPMorgan Healthcare Conference
8. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
9. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
10. Zimmer Reports Fourth Quarter and 2007 Financial Results
11. Zimmer Holdings to Present at Merrill Lynch Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ield University are in the hope of using stem cell... by creating embryonic stem cells // from the inne...he researchers have tried to regenerate the damage... make them divide into required cell, which has le...
...ry popular drink in Europe and more so in Germany....ave manufactured a healthy beer called karla //, w...nd also prevent cancer. The beer is made form her...oya extract, folic acid and vitamins. It is also w...
...ealed that a IQ level is directly linked to growth...s directly linked to the IQ level of the child, ac...rs. This study also reveals that the children who ... comparison to shorter children. If growth hormone...
... AIDS Day, the Vatican has condemned a culture of ...rted that the best way to prevent the spread // o...icted to marriage and intensifying the strength of...ternational day of action on HIV and AIDS, is comm...
Other Medicine News:
(Date:9/4/2008)...cian-Gynecologists States UFE Meets Level,A Eviden... Interventional,Radiology Treatment Is Safe, Effec...FAX, Va., Sept. 4 /PRNewswire-USNewswire/ -- The S...anization of nearly 4,500 doctors,scientists and ... health,care through minimally invasive treatment ...
(Date:9/4/2008)...t antiviral activity and favorable safety ..., Sept. 4 /- Idenix,Pharmac...al company engaged,in the discovery and developmen...her infectious diseases, today announced that it h... IDX899, a non-nucleoside reverse,transcriptase in...
(Date:9/3/2008)...swire-FirstCall/ -- Simcere,Pharmaceutical Group (...of,branded generic pharmaceuticals and manufacture... (also known as Endostar) in China,announced the ... At the request of the SFDA, Simcere initiated a P...ety and therapeutic efficacy of Endu, a modified,v...
(Date:9/3/2008)...Newswire/ -- Panacea Pharmaceuticals,Inc. today a...737 covering,antibodies against human aspartyl (as...human cancer biomarker and therapeutic target. The... the Massachusetts Institute of,Technology (MIT) a... patent,for development of human cancer diagnostic...
Breaking Medicine Technology:Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Patient Safety Authority Board of Directors Names Infection Advisory Panel 1034 1Patient Safety Authority Board of Directors Names Infection Advisory Panel 1034 2Patient Safety Authority Board of Directors Names Infection Advisory Panel 1034 3Patient Safety Authority Board of Directors Names Infection Advisory Panel 1034 4Patient Safety Authority Board of Directors Names Infection Advisory Panel 1034 5Patient Safety Authority Board of Directors Names Infection Advisory Panel 1034 6Patient Safety Authority Board of Directors Names Infection Advisory Panel 1034 7Patient Safety Authority Board of Directors Names Infection Advisory Panel 1034 8Patient Safety Authority Board of Directors Names Infection Advisory Panel 1034 9Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death Heart Attack and Stroke but Increases Risk of Heart Failure 245 1Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death Heart Attack and Stroke but Increases Risk of Heart Failure 245 2Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death Heart Attack and Stroke but Increases Risk of Heart Failure 245 3Takeda statement on ACTOS meta analysis published in the Journal of the American Medical Association 1027 1Takeda statement on ACTOS meta analysis published in the Journal of the American Medical Association 1027 2Other highlights in the September 11 JNCI 1024 1Other highlights in the September 11 JNCI 1024 2Other highlights in the September 11 JNCI 1024 3
CVC 223 is an assayed quality control material used for confirming the calibration and linearity of CO-Oximeter instrumentation.
...ol material used for monitoring the performance of...tation. It is for specific use on Bayer analyzers ...ions (280, 288, and 270) and the AVOX Systems CO-O... on the IRMA TRUpoint®. CC 527 is available i...
QC 623 is an assayed quality control material for blood gas and electrolyte instrumentation. It is available in four (4) levels for monitoring analyzer performance at varying points within the clinic
Equinox is a truly unique approach to cosmetic enhancement contact lenses and is worn as a conventional wear lens.
Medicine Products: